Smith & Nephew plc ADR (NPWA)
XFRA 
Summary
NPWA Chart
Smith & Nephew plc (SNN) Analyst/Investor Day Transcript
Smith & Nephew plc (SNN) Analyst/Investor Day Transcript
Smith & Nephew plc (SNN) Q3 2025 Sales Call Transcript
Smith & Nephew plc ( SNN ) Q3 2025 Sales Call November 6, 2025 3:30 AM EST Company Participants Deepak Nath - CEO & Director John Rogers - CFO & Executive Director Conference Call Participants Jack Reynolds-Clark - RBC Capital Markets, Research Division Veronika Dubajova - Citigroup Inc., Research Division Hassan Al-Wakeel - Barclays Bank PLC, Research Division Graham Doyle - UBS Investment Bank, Research Division Kane Slutzkin - Deutsche Bank AG, Research Division Julien Dormois - Jefferies LLC, Research Division David Adlington - JPMorgan Chase & Co, Research Division Presentation Operator Good morning. Thank you for attending today's Smith & Nephew Quarter 3 2025 Trading Report.
Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release
Smith & Nephew plc maintains a 'Hold' rating due to valuation concerns and limited near-term upside despite recent operational improvements. Sequential growth across all business units and a 100 basis point trading margin expansion support management's confidence in achieving full-year guidance. Technical analysis reveals significant resistance at $38 and $40-$42, with bearish intermediate signals suggesting potential price weakness over the next 6-10 months.
Smith & Nephew plc ADR (NPWA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Smith & Nephew plc ADR ever had a stock split?
Smith & Nephew plc ADR Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Deepak S. Nath CEO | XFRA Exchange | US83175M2052 ISIN |
| GB Country | 17,349 Employees | 3 Oct 2025 Last Dividend | 15 Oct 2014 Last Split | 16 Nov 1999 IPO Date |
Overview
Smith & Nephew plc is a globally recognized company specializing in the development, manufacture, marketing, and sale of medical devices and services. Founded in 1856 and based in Watford, the United Kingdom, the company operates internationally, catering to the healthcare sector through its three main segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Smith & Nephew's mission is to improve the quality of life for people around the world by providing innovative and effective medical solutions.
Products and Services
Smith & Nephew offers a comprehensive range of medical devices and services across various specializations:
- Knee Implant Products: Designed for knee replacement procedures, these products aim to restore knee function with durable and efficient implants.
- Hip Implants: Focused on revision procedures, these implants are essential for correcting previous surgeries and ensuring longevity and comfort.
- Trauma and Extremities Products: This range includes both internal and external devices crucial for the stabilization of severe fractures, deformity correction procedures, and other reconstruction needs.
- Sports Medicine Joint Repair: Comprising instruments, technologies, and implants for minimally invasive surgeries, these products target soft tissue injuries and degenerative conditions across various joints including the shoulder, knee, hip, and smaller joints.
- Arthroscopic Enabling Technologies: Offering fluid management equipment, high-definition cameras, digital image capture systems, scopes, light sources, monitors, and various tissue resection devices, these technologies assist in surgical procedures and visualization inside the joints.
- Ear, Nose, and Throat (ENT) Solutions: Smith & Nephew provides specialized solutions for ENT procedures, enhancing the treatment quality and comfort for patients.
- Advanced Wound Care: The company's advanced wound care products address both acute and chronic wounds, including leg wounds, diabetic ulcers, pressure ulcers, burns, and post-operative wounds. These include:
- Advanced Wound Bioactives: Featuring biologics and other bioactive technologies for debridement and dermal repair/regeneration.
- Regenerative Medicine Products: Offering solutions such as skin, bone graft, and articular cartilage substitutes aimed at facilitating natural healing and regeneration.
- Advanced Wound Devices: Includes traditional and single-use negative pressure wound therapy systems and hydrosurgery systems, which are critical for effective wound management.
Contact Information
